Amwill Health Care Ltd Stock Price Today (NSE: AMWILL)
Fundamental Score
Amwill Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amwill Health Care Ltd share price today is ₹45.19, up +5.96% on NSE/BSE as of 17 June 2026. Amwill Health Care Ltd (AMWILL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹85.98 (Cr). The 52-week high for AMWILL share price is ₹83.49 and the 52-week low is ₹28.91. At a P/E ratio of 10.64x, AMWILL is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 24.85% and a debt-to-equity ratio of 0.00.
Amwill Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Amwill Health Care Ltd share price chart: -8.18% return over the past month. 52-week high ₹83.49, 52-week low ₹28.91.
Amwill Health Care Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹36.00 | ₹36.04 | ₹36.00 | ₹36.04 | 43.20K (Cr) | |
| ₹34.33 | ₹34.33 | ₹34.33 | ₹34.33 | 3.60K (Cr) | |
| ₹32.32 | ₹33.93 | ₹32.32 | ₹32.70 | 22.80K (Cr) | |
| ₹32.38 | ₹32.38 | ₹31.10 | ₹32.32 | 13.20K (Cr) | |
| ₹32.38 | ₹32.38 | ₹32.38 | ₹32.38 | 1.20K (Cr) | |
| ₹30.85 | ₹32.38 | ₹30.85 | ₹32.38 | 8.40K (Cr) | |
| ₹31.00 | ₹31.00 | ₹30.85 | ₹30.85 | 3.60K (Cr) | |
| ₹31.20 | ₹31.85 | ₹31.00 | ₹31.85 | 9.60K (Cr) | |
| ₹31.00 | ₹32.50 | ₹30.69 | ₹32.50 | 46.80K (Cr) | |
| ₹32.35 | ₹33.00 | ₹32.30 | ₹32.30 | 68.40K (Cr) |
Amwill Health Care Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹34.33 | ₹36.04 | ₹34.33 | ₹36.04 | +4.98% | |
| ₹35.48 | ₹36.40 | ₹30.69 | ₹32.70 | -7.84% | |
| ₹29.50 | ₹38.50 | ₹28.91 | ₹34.89 | +18.27% | |
| ₹33.15 | ₹36.98 | ₹28.95 | ₹28.95 | -12.67% | |
| ₹35.96 | ₹37.79 | ₹34.50 | ₹34.85 | -3.09% | |
| ₹48.90 | ₹50.90 | ₹36.25 | ₹39.55 | -19.12% | |
| ₹42.05 | ₹47.94 | ₹34.00 | ₹47.63 | +13.27% | |
| ₹56.00 | ₹57.00 | ₹40.00 | ₹42.05 | -24.91% | |
| ₹53.30 | ₹55.96 | ₹50.00 | ₹54.00 | +1.31% | |
| ₹58.99 | ₹62.99 | ₹53.01 | ₹53.24 | -9.75% | |
| ₹60.30 | ₹65.20 | ₹55.00 | ₹55.77 | -7.51% | |
| ₹73.50 | ₹74.00 | ₹58.20 | ₹60.30 | -17.96% |
AI Research Briefing
Powered by Gemini · 2026-04-15
Cheap micro-cap derma play with slowing growth and IT security concerns; valuation is a value trap.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The company successfully recovered from an IT security incident. Trading window closed for the half year and financial year ending March 31, 2026. Reappointed SPR & Co as internal auditor for FY26.
CORE STORY (THE REAL GAME)
Amwill is a derma-cosmetic play, riding the wave of increased spending on personal care and aesthetics in India. Not a generics volume game, but a brand and formulation story.
- Industry tailwinds in Indian pharma
- Undervalued compared to industry
- High ROE and ROCE
- New product launches
- Significant order wins
- Improvement in quarterly sales growth
- Micro-cap = liquidity risk
- Slowing revenue growth
- Dependence on contract manufacturers
- IT security incident
Promoter holding stable at 70.65%. FII/DII negligible.
Indian pharma sector evolving towards biologics and biosimilars.
Profit converting to cash - Free Cash Flow 5Y: ₹7.66 Cr
Next 3-6 months depend on revenue growth and margin stability. Watch out for execution on new product launches.
Primary Thesis Risk
Slowing revenue growth in a micro-cap with liquidity risk.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amwill Health Care Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amwill Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMWILL across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (24.85%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (27.56%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (23.43%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 10.64 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (70.65%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Profit Decline Concern (-40.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-8.42%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Institutional Interest (FII+DII: 1.16%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amwill Health Care Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Amwill Health Care Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amwill Health Care LtdAmwill Health C...Selected✓ AMWILL • 544353 | 36.2/100 | ₹45.19₹45 | ₹85.98₹85.98 | 10.64Average 10.6 Average | 24.85%Excellent 24.85% Excellent | 27.56%Excellent 27.56% Excellent | 0.00Excellent 0.0 Excellent | — — | — — | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Amwill Health Care Ltd Quarterly Performance
Latest quarterly metrics for AMWILL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-8.42%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-40.64%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Amwill Health Care Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMWILL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amwill Health Care Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amwill Health Care Ltd (AMWILL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Amwill Health Care Ltd
About AMWILL (Amwill Health Care Ltd)
Amwill Health Care Ltd is a pharmaceutical enterprise dedicated to innovating and delivering advanced healthcare solutions. With a strong commitment to research and development, AM...WILL focuses on creating novel therapeutic interventions and improving existing treatment modalities across various medical disciplines. The company is structured around a multifaceted approach, encompassing the entire lifecycle of pharmaceutical products, from initial discovery and preclinical studies to clinical trials, regulatory approvals, manufacturing, and commercialization. AMWILL's core strength lies in its team of experienced scientists, clinicians, and industry professionals who collaborate to address unmet medical needs and enhance patient outcomes. Through strategic partnerships and a continuous pursuit of scientific excellence, AMWILL strives to be a catalyst for progress in the ever-evolving landscape of healthcare. AMWILL Health Care Ltd distinguishes itself through its state-of-the-art manufacturing facilities and rigorous quality control processes, ensuring that its products consistently meet the highest standards of safety and efficacy. The company's diverse portfolio includes a wide array of pharmaceutical formulations, catering to a broad spectrum of therapeutic areas, including but not limited to, cardiovascular health, oncology, neurology, and infectious diseases. By embracing cutting-edge technologies and adhering to stringent regulatory guidelines, AMWILL ensures that its offerings are not only effective but also accessible to patients worldwide. The company actively invests in building a robust distribution network and fostering strong relationships with healthcare providers, aiming to facilitate the seamless delivery of its products to those who need them most. Amwill Health Care Ltd is dedicated to corporate social responsibility, understanding that its role extends beyond providing medicines to fostering a healthier and more sustainable future. Through various initiatives, AMWILL actively supports community health programs, promotes environmental conservation, and upholds ethical business practices. The company is committed to transparency and accountability in all its operations, striving to earn the trust and respect of its stakeholders. By prioritizing innovation, quality, and social impact, AMWILL aims to be a trusted partner in healthcare, contributing to the well-being of individuals and communities around the globe. Its overarching goal is to transform lives through its commitment to pharmaceutical excellence and responsible corporate citizenship.
Company Details
Key Leadership
Latest News
AMWILL Share Price: Frequently Asked Questions
What is the current share price of Amwill Health Care Ltd?
Amwill Health Care Ltd (AMWILL) trades at ₹45.19 on NSE and BSE. Market cap ₹85.98 (Cr). Educational data only.
What is the P/E ratio of Amwill Health Care Ltd?
Amwill Health Care Ltd has a P/E of 10.64x vs industry average 31.77x.
What is the Bull Run score for Amwill Health Care Ltd?
Amwill Health Care Ltd has a Bull Run score of 36.2/100 based on 25+ financial parameters.
Does Amwill Health Care Ltd pay dividends?
Amwill Health Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amwill Health Care Ltd?
Amwill Health Care Ltd has ROE of 24.85%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amwill Health Care Ltd?
Amwill Health Care Ltd has debt-to-equity of 0.00.
Is Amwill Health Care Ltd a good investment?
Bull Run gives Amwill Health Care Ltd a score of 36.2/100. This is not investment advice — consult a SEBI-registered advisor.